AstraZeneca's ovarian cancer drug gets U.S. approval
December 19, 2014 at 14:33 PM EST
AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.